Is there a neuropathology of schizophrenia? Recent findings converge on altered thalamic-prefrontal cortical connectivity

Neuroscientist

Volumn 6, Issue 3, 2000, Pages 208-218

  Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Dopamine; GABA; Mediodorsal thalamus; Prefrontal cortex; Pyramidal neuron; Schizophrenia

Indexed keywords

HUMAN; NERVE TRACT; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; THALAMUS;

EID: 0034081370     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385840000600311     Document Type: Review

References (81)

1. Andreasen NC. Symptoms, signs, and diagnosis of schizophrenia. Lancet 1995;346:477-81.
2. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, et al. Gender differences in onset of illness, treatment response, course, and biological indexes in first-episode schizophrenic patients. Am J Psychiatry 1995;152:698-703.
3. Nopoulos P, Flaum M, Andreasen NC. Sex differences in brain morphology in schizophrenia. Am J Psychiatry 1997;154:1648-54.
4. Harrison PJ. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 1999;122:593-624.
5. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, et al. MRI anatomy of schizophrenia. Biol Psychiatry 1999;45:1099-119.
6. Pearlson GD, Marsh L. Structural brain imaging in schizophrenia: a selective review. Biol Psychiatry 1999;46:627-49.
7. Van Horn JD, McManus IC. Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle: brain ratio (VBR). Br J Psychiatry 1992;160:687-97.
8. Lawrie SM, Abukmeil SS. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 1998;172:110-20.
9. Lim KO, Tew W, Kushner M, Chow K, Matsumoto B, DeLisi LE. Cortical gray matter volume deficit in patients with first-episode schizophrenia. Am J Psychiatry 1996;153:1548-53.
10. Zipursky RB, Lambe EK, Kapur S, Mikulis DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry 1998;55:540-6.
11. Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody D, Alvir JMJ, et al. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry 1992;49:531-7.
12. DeLisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Gupta SM, et al. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry 1991;29:159-75.
13. Cannon TD, Mednick SA, Parnas J, Schulsinger F, Praestholm J, Vestergaard A. Developmental brain abnormalities in the offspring of schizophrenic mothers I. Contributions of genetic and perinatal factors. Arch Gen Psychiatry 1993;50:551-64.
14. Lawrie SM, Whalley H, Kestelman JN, Abukmeil SS, Byrne M, Hodges A, et al. Magnetic resonance imaging of the brain in subjects at high risk of developing schizophrenia. Lancet 1999;353:30-3.
15. Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, et al. Progressive cortical change during adolescence in childhood-onset schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 1999;56:649-54.
16. Daniel DG, Goldberg TE, Gibbons RD, Weinberger DR. Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controls. Biol Psychiatry 1991;30:887-903.
17. Reveley AM, Reveley MA, Clifford CA, Murray RM. Cerebral ventricular size in twins discordant for schizophrenia. Lancet 1982;1:540-1.
18. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 1990;322:789-94.
19. Shenton ME, Wible CG, McCarley RW. A review of magnetic resonance imaging of brain abnormalities in schizophrenia. In: Krishnan KR and Doraiswamy PM, editors. Brain imaging in clinical psychiatry. New York: Marcel Dekker; 1997. p. 297-380.
20. Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986;65(3-4):303-26.
21. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991;48:625-32.
22. Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999;45:395-402.
23. Akil M, Lewis DA. The cytoarchitecture of the entorhinal cortex in schizophrenia. Am J Psychiatry 1997;154:1010-12.
24. Krimer LS, Herman MM, Saunders RC, Boyd JC, Hyde TM, Carter JM, et al. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex 1997;7:732-9.
25. Heinsen H, Gössmann E, Rüb U, Eisnemenger W, Bauer M, Ulmar G, et al. Variability in the human entorhinal region may confound neuropsychiatric diagnoses. Acta Anat 1996;157:226-37.
26. Akbarian S, Bunney Jr WE, Potkin SG, Wigal SB, Hagman JO, Sandman CA, et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993;50:169-77.
27. Akbarian S, Kim JJ, Potikin SG, Hetrick WP, Bunney Jr WE, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996;53:425-36.
28. Anderson S, Volk DW, Lewis DA. Increased density of microtubule-associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res 1996;19:111-19.
29. Duncan GE, Sheitman BB, Leiberman JA. An integrated view of pathophysiological models of schizophrenia. Brain Res Rev 1999;29:250-64.
30. Benes FM. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain. Schizophr Bull 1998;24:219-30.
31. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999;45:17-25.
32. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998-1007.
33. Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991;41:1-24.
34. Goldman-Rakic PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry 1994;6:348-57.
35. Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 1992;49:975-82.
36. Fuster JM. The prefrontal cortex: anatomy, physiology, and neuropsychology of the frontal lobe. Philadelphia: Lippincott-Raven; 1997.
37. Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry 1986;43:114-24.
38. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995;52:805-18.
39. Woo T-U, Miller JL, Lewis DA. Parvalbumin-containing cortical neurons in schizophrenia. Am J Psychiatry 1997;154:1013-15.
40. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol Psychiatry 1993;34:768-72.
41. Daviss SR, Lewis DA. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 1995;59:81-96.
42. Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 1999;56:537-47.
43. Mohamed S, Paulsen JS, O'Leary D, Arndt S, Andreasen NC. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry 1999;56:749-54.
44. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CTW, et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996;153:1554-63.
45. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 1997;154:688-90.
46. Stanley JA, Williamson PC, Drost DJ, Rylett RJ, Carr TJ, Malla A, et al. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophr Bull 1996;22:597-609.
47. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch Gen Psychiatry 1991;48:563-8.
48. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett RJ, Malla A, et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry 1995;52:399-406.
49. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998;55:215-24.
50. Thune JJ, Hofsten DE, Uylings HBM, Pakkenberg B. Total neuron numbers in the prefrontal cortex in schizophrenia. Soc Neurosci Abstr 1998;24:985.
51. Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch Gen Psychiatry 1997;54:943-52.
52. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WST. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for "hypofrontality". Mol Psychiatry 1999;4:39-45.
53. Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci U S A 1996;93:14182-7.
54. Honer WG, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 1999;91:1247-55.
55. Andreasen NC, Arndt S, Swayze V II, Cizaldo T, Flaum M, O'Leary D, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994;266:294-8.
56. Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A, et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 1996;153:191-9.
57. Frazier JA, Giedd JN, Hamburger SD, Albus KE, Kaysen D, Vaituzis AC, et al. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry 1996;53:617-24.
58. Wolkin A, Rusinek H, Vaid G, Arena L, Lafargue T, Sanfilipo M, et al. Structural magnetic resonance image averaging in schizophrenia. Am J Psychiatry 1998;155:1064-73.
59. Portas CM, Goldstein JM, Shenton ME, Hokama HH, Wible CG, Fischer I, et al. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry 1998;43:649-59.
60. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990;47:1023-8.
61. Manaye KF, Liang C-L, Hicks PB, German D, Young KA. Nerve cell numbers in thalamic anterior and mediodorsal nuclei are selectively reduced in schizophrenia. Soc Neurosci Abstr 1998;24:1236.
62. Danos P, Baumann B, Bernstein H-G, Franz M, Stauch R, Northoff G, et al. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res: Neuroimaging 1998;82:1-10.
63. Jones EG, Hendry SHC. Differential calcium binding protein immunoreactivity distinguishes classes of relay neurons in monkey thalamic nuclei. Eur J Neurosci 1989;1:222-46.
64. Melchitzky DS, Sesack SR, Lewis DA. Parvalbumin-immunoreactive axon terminals in monkey and human prefrontal cortex: laminar, regional and target specificity of type I and type II synapses. J Comp Neurol 1999;408:11-22.
65. Cruz DA, Melchitzky DS, Lewis DA. Parvalbumin-immunoreactive varicosities are selectively decreased in the thalamic recipient zone of the prefrontal cortex in schizophrenia. Soc Neurosci Abstr 1999;25:817.
66. Parnavelas JG, Lynch G, Brecha N, Cotman CW, Globus A. Spine loss and regrowth in hippocampus following deafferentation. Nature 1974;248:71-3.
67. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000;57:65-73.
68. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998;65:446-53.
69. Pierri JN, Edgar CL, Lewis DA. Somal size of prefrontal cortical pyramidal neurons in the thalamic recipient zone of subjects with schizophrenia. Soc Neurosci Abstr 1998;24:987.
70. Hendry SHC, Jones EG. Activity-dependent regulation of GABA expression in the visual cortex of adult monkeys. Neuron 1988;1:701-12.
71. Benson DL, Huntsman MM, Jones EG. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cereb Cortex 1994;4:40-51.
72. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney Jr WE, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995;52:258-66.
73. 67 mRNA expression in a subset of prefrontal cortical GABA neurons in schizophrenia. Arch Gen Psychiatry 2000; 57:237-45.
74. Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo T-U. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 1999;46:616-26.
75. Lewis DA. Chandelier cells: shedding light on altered cortical circuitry in schizophrenia. Mol Psychiatry 1998;3:468-71.
76. Woo T-U, Whitehead RE, Melchitzky DS, Lewis DA. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998;95:5341-6.
77. Pierri JN, Chaudry AS, Woo T-U, Lewis DA. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 1999;156:1709-19.
78. Lewis DA, Melchitzky DS, Gonzalez-Burgos G, Sesack SR, Barrionuevo G. Intrinsic axon terminals of layer 3 pyramidal neurons in monkey prefrontal cortex: differences in the synaptic targets of local and long-range collaterals. Soc Neurosci Abstr 1999;25:362.
79. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991;48:996-1001.
80. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Lewis DA. Lamina-specific alteration in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 1999;156:1580-9.
81. Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci USA 1989;86:9015-19.